Merger Mania in Biopharma: Will Information Professionals be Victims, Witnesses or Winners?
Jinfo Article
20th December 2013
Abstract
With biopharmaceutical companies under pressure to maintain revenues and suffering from the upcoming expiry of key patents, more mergers and acquisitions are likely to take place. Yulia Aspinall examines how information professionals can put their skills to good use to change the challenge of possible redundancy into an opportunity, where the information services team emerges stronger post M&A.
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Merger Mania in Biopharma: Will Information Professionals be Victims, Witnesses or Winners?
- Link to this page
- View printable version
- Securing Senior Management Buy-In
Thursday, 19th December 2013 - Mini Review: IngentaConnect
Friday, 13th December 2013 - Enterprise Information: Busting Some Myths
Friday, 29th November 2013 - Engaging Stakeholders in Dialogue about Value: The Art of Persuasion
Friday, 27th September 2013 - Return on Information Investment - Breakthrough At Last?
Monday, 12th August 2013
- Brush up on Benchmarking with Reports from Best Practices
Monday, 23rd September 2013 - Biopharma Companies in a State of Flux
Friday, 2nd August 2013